In conclusion, together with our in vitro studies, our results illustrated that HS3ST1 could promote the proliferation of human NSCLC cells, modulate cell cycle distribution, and inhibit apoptosis by regulating the SPOP/FADD/NF-κB pathway. Here, HS3ST1 is linked to non-small cell lung carcinoma.